These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30732601)

  • 1. Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia.
    Limenih YA; Workie DL
    BMC Public Health; 2019 Feb; 19(1):165. PubMed ID: 30732601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
    PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and transmission dynamics of multi-drug resistant tuberculosis strains using whole genome sequencing in the Amhara region, Ethiopia.
    Shibabaw A; Gelaw B; Ghanem M; Legall N; Schooley AM; Soehnlen MK; Salvador LCM; Gebreyes W; Wang SH; Tessema B
    BMC Genomics; 2023 Jul; 24(1):400. PubMed ID: 37460951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
    PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Time to Death of Patients with Multidrug-Resistant Tuberculosis at Saint Peter's Specialized Hospital.
    Wotale TW; Terefe AN; Fufa JA
    J Res Health Sci; 2021 May; 21(2):e00513. PubMed ID: 34465635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
    Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B
    Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient's record data from 2016 to 2021: retrospective study.
    Wotale TW; Lelisho ME; Negasa BW; Tareke SA; Gobena WE; Amesa EG
    Sci Rep; 2024 Oct; 14(1):23912. PubMed ID: 39397064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.
    Ambaye GY; Tsegaye GW
    Ethiop J Health Sci; 2021 Jan; 31(1):25-34. PubMed ID: 34158749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study.
    Ketema DB; Muchie KF; Andargie AA
    BMC Public Health; 2019 Nov; 19(1):1481. PubMed ID: 31703667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
    Yihunie Akalu T; Muchie KF; Alemu Gelaye K
    PLoS One; 2018; 13(6):e0199320. PubMed ID: 29927980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study.
    Kassa GM; Tadesse A; Gelaw YA; Alemayehu TT; Tsegaye AT; Tamirat KS; Akalu TY
    Epidemiol Infect; 2020 Oct; 148():e258. PubMed ID: 33054897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.
    Meressa D; Hurtado RM; Andrews JR; Diro E; Abato K; Daniel T; Prasad P; Prasad R; Fekade B; Tedla Y; Yusuf H; Tadesse M; Tefera D; Ashenafi A; Desta G; Aderaye G; Olson K; Thim S; Goldfeld AE
    Thorax; 2015 Dec; 70(12):1181-8. PubMed ID: 26506854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
    Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K
    Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial Frailty Survival Model for Multidrug-Resistant Tuberculosis Mortality in Amhara Region, Ethiopia.
    Woya AA; Tekile AK; Basha GW
    Tuberc Res Treat; 2019; 2019():8742363. PubMed ID: 30693105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of standardized injectable shorter regimen for multi-drugs resistant tuberculosis in Ethiopia: a retrospective cohort study.
    Achalu DL; Kiltu AB; Teferi M; Mohammed FG; Workneh BD; Beyene KA; Gebretekle GB; Ali EE
    BMC Infect Dis; 2024 Aug; 24(1):837. PubMed ID: 39152383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
    Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
    Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Khat Chewing and Clinical Conditions Determine the Epidemiology of Primary Drug Resistance Tuberculosis in Amhara Region of Ethiopia: A Multicenter Study.
    Kassa GM; Merid MW; Muluneh AG
    Infect Drug Resist; 2021; 14():2449-2460. PubMed ID: 34234475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.